Investing News

Carl Icahn and Illumina Proxy Fight Heats Up

Biotech firm Illumina (ILMN) told shareholders not to vote for the board nominees put forward by billionaire activist investor Carl Icahn.

Articles You May Like

7 REITs to Sell Before They Crumble Under Pressure
3 AI Stocks to Sell in June Before They Crash and Burn
7 Sleeper Stocks to Buy Before Investors Wake Up
3 Top-Rated Large-Cap Stocks to Buy (and Never Sell)
3 Cheap Small-Cap Stocks to Buy Before the Next Breakout